Your browser doesn't support javascript.
loading
Outcomes Using Focused Shockwave for Treatment of Bone Stress Injury in Runners.
Beling, Alexandra; Saxena, Amol; Hollander, Karsten; Tenforde, Adam S.
Affiliation
  • Beling A; Spaulding Rehabilitation Hospital, 300 First Avenue, Charlestown, MA 02129, USA.
  • Saxena A; Palo Alto Medical Foundation, Palo Alto, CA 94301, USA.
  • Hollander K; Institute of Interdisciplinary Exercise Science and Sports Medicine, Medical School Hamburg, 20457 Hamburg, Germany.
  • Tenforde AS; Spaulding Rehabilitation Hospital, 300 First Avenue, Charlestown, MA 02129, USA.
Bioengineering (Basel) ; 10(8)2023 Jul 25.
Article in En | MEDLINE | ID: mdl-37627770
ABSTRACT
Bone stress injury (BSI) is a common overuse injury that can result in prolonged time away from sport. Limited studies have characterized the use of extracorporeal shockwave therapy (ESWT) for the treatment of BSI. The purpose of this study was to describe the use of ESWT for the management of BSI in runners. A retrospective chart review was performed to identify eligible patients in a single physician's clinic from 1 August 2018 to 30 September 2022. BSI was identified in 40 runners with 41 injuries (28 females; average age and standard deviation 30 ± 13 years; average pre-injury training 72 ± 40 km per week). Overall, 63% (n = 26) met the criteria for moderate- or high-risk Female or Male Athlete Triad categories. Runners started ESWT at a median of 36 days (IQR 11 to 95 days; range 3 days to 8 years) from BSI diagnosis. On average, each received 5 ± 2 total focused ESWT treatments. Those with acute BSI (ESWT started <3 months from BSI diagnosis) had an average return to run at 12.0 ± 7.5 weeks, while patients with delayed union (>3 months, n = 3) or non-union (>6 months, n = 9) had longer time for return to running (19.8 ± 14.8 weeks, p = 0.032). All runners returned to pain-free running after ESWT except one runner with non-union of grade 4 navicular BSI who opted for surgery. No complications were observed with ESWT. These findings suggest that focused ESWT may be a safe treatment for the management of BSI in runners.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Bioengineering (Basel) Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Bioengineering (Basel) Year: 2023 Document type: Article Affiliation country: United States
...